Equasens Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Public

  • Employees
  • 834

Employees

  • Stock Symbol
  • EQS

Stock Symbol

  • Investments
  • 28

  • Share Price
  • $29.46
  • (As of Wednesday Closing)

Equasens General Information

Description

Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centers) and patients in both primary and secondary care sectors. The various activities that the company is involved in include: pharmacy software publishing and integration, publishing of IT solutions for health and medical/social establishments, and development of solutions and infrastructures for e-Health. With operations in France (its key revenue-generating market), Italy, Belgium, Germany, Ireland, and the United Kingdom, it is developing the healthcare platform and an ecosystem in France and Europe, benefiting people by making its technology services available.

Contact Information

Formerly Known As
Pharmagest, Pharmagest Group, Pharmagest Interactive
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 5 Allée de Saint-Cloud
  • 54600 Villers-les-Nancy
  • France
+33 0
Primary Industry
Business/Productivity Software
Other Industries
Other Software
IT Consulting and Outsourcing
Stock Exchange
PAR
Vertical(s)
TMT
Corporate Office
  • 5 Allée de Saint-Cloud
  • 54600 Villers-les-Nancy
  • France
+33 0

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Equasens Stock Performance

As of 18-Nov-2026, Equasens’s stock price is $29.46. Its current market cap is $443M with 15M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$29.46 $30.30 $28.57 - $53.39 $443M 15M 25.3K $2.92

Equasens Financials Summary

As of 31-Dec-2025, Equasens has a trailing 12-month revenue of $267M.

In Thousands,
USD
TTM 31-Dec-2025 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 815,274 815,274 715,784 1,018,332
Revenue 266,796 266,796 234,547 237,827
EBITDA 73,359 73,359 62,758 72,965
Net Income 44,364 44,364 39,206 50,908
Total Assets 515,641 515,641 414,160 435,577
Total Debt 71,518 71,518 58,093 72,980
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Equasens Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Equasens‘s full profile, request access.

Request a free trial

Equasens Patents

Equasens Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-2813476-A1 External sales and consulting support network for products and articles Active 24-Aug-2000
FR-2813476-B1 External sales and consulting support network for products and articles Inactive 24-Aug-2000
EP-1182601-A1 External shopping aid and recommendation network for products and articles Inactive 24-Aug-2000 G06Q30/06

Equasens Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Equasens Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Equasens‘s full profile, request access.

Request a free trial

Equasens Investments & Acquisitions (28)

Equasens’s most recent deal was a Merger/Acquisition with Erevo (Education and Training Services (B2B)). The deal was made on 01-Dec-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Erevo (Education and Training Services (B2B)) 01-Dec-2025 Merger/Acquisition Education and Training Services (B2B)
Calimed Santé 27-Dec-2024 Merger/Acquisition Enterprise Systems (Healthcare)
Digipharmacie 02-Jan-2024 Merger/Acquisition Other Financial Services
Apotheken Datenverarbeitung 23-Nov-2023 Merger/Acquisition Enterprise Systems (Healthcare)
Atoopharm 06-Apr-2023 Merger/Acquisition Educational and Training Services (B2C)
You’re viewing 5 of 28 investments and acquisitions. Get the full list »

Equasens ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

18.71 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Health Care IT Services

Subindustry

of 50

Rank

Percentile

To view Equasens’s complete esg history, request access »

Equasens Exits (3)

Equasens’s most recent exit was on 01-Jan-2015 from Int Écum. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Int Écum 01-Jan-2015 Completed
DOmedic 01-May-2011 Completed
Int Écum 01-Dec-2010 Secondary Transaction - Private Completed
To view Equasens’s complete exits history, request access »

Equasens Affiliates

Subsidiaries (17)

Name Industry Location Year Founded
Speech2Sense Roubaix, France 2019
Digipharmacie Paris, France 2019
Erevo (Education and Training Services (B2B)) Marseille, France 2018
Nanceo Clichy, France 2015
Kapelse Villers-Les-Nancy, France 2013
You’re viewing 5 of 17 affiliates. Get the full list.  »

Equasens FAQs

  • When was Equasens founded?

    Equasens was founded in 1996.

  • Where is Equasens headquartered?

    Equasens is headquartered in Villers-les-Nancy, France.

  • What is the size of Equasens?

    Equasens has 834 total employees.

  • What industry is Equasens in?

    Equasens’s primary industry is Business/Productivity Software.

  • Is Equasens a private or public company?

    Equasens is a Public company.

  • What is Equasens’s stock symbol?

    The ticker symbol for Equasens is EQS.

  • What is the current stock price of Equasens?

    As of 18-Nov-2026 the stock price of Equasens is $29.46.

  • What is the current market cap of Equasens?

    The current market capitalization of Equasens is $443M.

  • What is Equasens’s current revenue?

    The trailing twelve month revenue for Equasens is $267M.

  • What is Equasens’s annual earnings per share (EPS)?

    Equasens’s EPS for 12 months was $2.92.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process